A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosis
Advanced Science · 2025-01 · 12 (1)
DOI: 10.1002/advs.202405597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 28.10.2024. Verfasst von Junyue Xing und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center for Cardiovascular Dise…. Hauptthemen laut MEDLINE: Doxorubicin, Ferroptosis, Cardiotoxicity. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province, Health Science and Technology Innovation Program of Henan Province for Excellent Young Scholars.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Doxorubicin (DOX), a potent antineoplastic agent, is commonly associated with cardiotoxicity, necessitating the development of strategies to reduce its adverse effects on cardiac function. Previous research has demonstrated a strong correlation between DOX‐induced cardiotoxicity and the activation of oxidative stress pathways. This work introduces a novel antioxidant therapeutic approach, utilizing libraries of tannic acid and N‐acetyl‐L‐cysteine‐protected bimetallic cluster nanozymes. Through extensive screening for antioxidative enzyme‐like activity, an optimal bimetallic nanozyme (AuRu) is identified that possess remarkable antioxidant characteristics, mimicking catalase‐like enzymes. Theoretical calculations reveal the surface interactions of the prepared nanozymes that simulate the hydrogen peroxide decomposition process, showing that these bimetallic nanozymes readily undergo OH⁻ adsorption and O₂ desorption. To enhance cardiac targeting, the atrial natriuretic peptide is conjugated to the AuRu nanozyme. These cardiac‐targeted bimetallic cluster nanozymes, with their anchoring capability, effectively reduce DOX‐induced cardiomyocyte ferroptosis and PANoptosis without compromising tumor treatment efficacy. Thus, the therapeutic approach demonstrates significant reductions in chemotherapy‐induced cardiac cell death and improvements in cardiac function, accompanied by exceptional in vivo biocompatibility and stability. This study presents a promising avenue for preventing chemotherapy‐induced cardiotoxicity, offering potential clinical benefits for cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Central China Subcenter of National Center for Cardiovascular Diseases, Henan Cardiovascular Disease Center, Fuwai Central-China Cardiov…
- Henan Key Laboratory of Chronic Disease Management, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, Henan, 451464, China.
- Zhengzhou Key Laboratory of Cardiovascular Aging, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, Henan, 451464, China.
- Department of Cardiovascular Diseases the First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
- School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, 261053, China.
- CAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules (CAS), CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
ORCID-Profile: Kelong Fan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
- Health Science and Technology Innovation Program of Henan Province for Excellent Young Scholars
- Henan Provincial Science and Technology Research Project
- Science and Technology Innovation Talents in Universities of Henan Province
Zitieren
APA
Xing, J., Ma, X., Yu, Y., Xiao, Y., Chen, L., Yuan, W., Wang, Y., Liu, K., Guo, Z., Tang, H., Fan, K., & Jiang, W. (2025). A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosis. Advanced Science, 12(1). https://doi.org/10.1002/advs.202405597
Vancouver
Xing J, Ma X, Yu Y, Xiao Y, Chen L, Yuan W, et al. A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosis. Advanced Science. 2025;12(1). doi:10.1002/advs.202405597
BibTeX
@article{Xing2025,
author = {Xing, Junyue and Ma, Xiaohan and Yu, Yanan and Xiao, Yangfan and Chen, Lu and Yuan, Weining and Wang, Yingying and Liu, Keyu and Guo, Zhiping and Tang, Hao and Fan, Kelong and Jiang, Wei},
title = {A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosis},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {1},
doi = {10.1002/advs.202405597}
}
EUVIMED